These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3128396)

  • 1. Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals.
    Torosian MH; Mullen JL; Miller EE; Zinnser KR; Buzby GP
    Cancer; 1988 May; 61(9):1731-5. PubMed ID: 3128396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein intake and 5-fluorouracil toxicity in tumor-bearing animals.
    Torosian MH; Jalali S; Nguyen HQ
    J Surg Res; 1990 Oct; 49(4):298-301. PubMed ID: 2214738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced tumor response to cycle-specific chemotherapy by pulse total parenteral nutrition.
    Torosian MH; Mullen JL; Stein TP; Miller EE; Zinsser KR; Buzby GP
    J Surg Res; 1985 Aug; 39(2):103-13. PubMed ID: 3927061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enteral formulas on methotrexate toxicity.
    Chevreau N; Funk-Archuleta M
    Nutr Cancer; 1995; 23(2):185-204. PubMed ID: 7644387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics.
    Mihranian MH; Wang YM; Daly JM
    Cancer; 1984 Nov; 54(10):2268-71. PubMed ID: 6488146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in serum levels, anti-tumor activity and toxicity of methotrexate in rats after a short period of nutritional depletion.
    Dunki Jacobs PB; Ruevekamp M; Varossiau FJ; Hart GA; de Graaf PW
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):415-22. PubMed ID: 2702995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced tumor response to cycle-specific chemotherapy by parenteral amino acid administration.
    Torosian MH; Mullen JL; Miller EE; Zinsser KR; Stein TP; Buzby GP
    JPEN J Parenter Enteral Nutr; 1983; 7(4):337-45. PubMed ID: 6413709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors--effective nitrogen traps independent of protein intake.
    Torosian MH; Nguyen HQ
    J Surg Res; 1989 Nov; 47(5):456-9. PubMed ID: 2811359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis.
    Fox AD; Kripke SA; De Paula J; Berman JM; Settle RG; Rombeau JL
    JPEN J Parenter Enteral Nutr; 1988; 12(4):325-31. PubMed ID: 3138440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nutritional repletion on host and tumor response to chemotherapy.
    Reynolds HM; Daly JM; Rowlands BJ; Dudrick SJ; Copeland EM
    Cancer; 1980 Jun; 45(12):3069-74. PubMed ID: 6770988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model.
    Kuiken NS; Rings EH; Havinga R; Groen AK; Tissing WJ
    Support Care Cancer; 2016 Mar; 24(3):1357-64. PubMed ID: 26335404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of methotrexate in rats preexposed to nitrous oxide.
    Ermens AA; Schoester M; Spijkers LJ; Lindemans J; Abels J
    Cancer Res; 1989 Nov; 49(22):6337-41. PubMed ID: 2804978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glutamine on methotrexate efficacy and toxicity.
    Rubio IT; Cao Y; Hutchins LF; Westbrook KC; Klimberg VS
    Ann Surg; 1998 May; 227(5):772-8; discussion 778-80. PubMed ID: 9605669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
    Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
    J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics.
    Charland SL; Bartlett D; Torosian MH
    JPEN J Parenter Enteral Nutr; 1994; 18(1):45-9. PubMed ID: 8164303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
    Goldman ID; Matherly LH
    NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.